Securitas® Financial Group
Understanding Breast Cancer in South Africa
Disclaimer: This article is for information only and is not a substitute for medical, legal, or financial advice. Please consult a qualified professional for guidance specific to you.
Breast Cancer
Why This Still Matters
Breast cancer remains the leading cancer among South African women. The most recent National Cancer Registry data confirms it accounts for around 23.2% of all female cancers, with a lifetime risk of about 1 in 27 for South African women (De Lima et al., 2025).
Two trends stand out. First, more women are now being diagnosed in their 40s compared with a decade ago. This shift reflects both lifestyle and reproductive changes, as well as better awareness and earlier detection. Second, too many women are still diagnosed at a late stage, which significantly worsens survival outcomes (De Lima et al., 2025; Malherbe et al., 2025).
Securitas® Financial Group
What the Latest Evidence Shows
Incidence and Who Is Affected
A 2025 Johannesburg hospital-based study found that women aged 40–49 made up a growing share of new breast cancer diagnoses, rising from 19.4% in 2012 to 26.8% in 2022 (De Lima et al., 2025). The study also noted that women increasingly presented with smaller tumours, likely due to improved community awareness and the wider uptake of clinical breast examinations in primary care.
Stage at Diagnosis
Late presentation remains the single biggest driver of poor outcomes. Between 50% and 80% of South African women are still diagnosed at stage III–IV disease (Malherbe et al., 2025).
Rural women face additional barriers, including long travel distances to clinics, transport costs, poor infrastructure, and limited health literacy. These factors delay help-seeking, referrals, and screening (Sarmah, Sibiya & Khoza, 2024).
Survival and Why Timing Matters
A 2024 meta-analysis published in JAMA Network Open estimated survival across sub-Saharan Africa at 79% at one year, 56% at three years, and 40% at five years (Limenih et al., 2024). The study highlighted that earlier diagnosis and faster treatment initiation dramatically improved survival odds.
HIV and Breast Cancer
South Africa’s high HIV prevalence adds another layer of complexity. The SABCHO (South African Breast Cancer and HIV Outcomes) study reported that 21% of women with stage I–III breast cancer were HIV positive, with a two-year overall survival of 72.4% compared with 80.0% among HIV-negative women (Ayeni et al., 2022).
More recently, Bauer et al. (2025) found that HIV-positive women with breast cancer had altered tumour–immune profiles and significantly shorter survival, even when HIV was well controlled on treatment.
South Africa’s Specific Challenges
Barriers extend beyond biology. In the SABCHO cohort, women living farther from diagnostic hospitals or served by rural facilities were far more likely to be diagnosed at a late stage. Lower levels of education and income also contributed to delayed presentation (Mapanga et al., 2023).
System-level constraints further worsen outcomes. South Africa has too few radiotherapy machines, oncology specialists, and pathology services, all of which contribute to delays in starting treatment (Malherbe et al., 2025).
Securitas® Financial Group
Practical Steps You Can Take
Know Your Normal and Act Early
Understanding how your breasts usually look and feel allows you to notice changes sooner. Lumps, nipple discharge, or skin changes should prompt an immediate check by a healthcare professional. Acting early remains the single most effective way to improve survival.
Clinical Breast Exams and Mammography
Public-sector clinics offer clinical breast examinations, a key tool in resource-limited settings.
In the private sector, the Radiological Society of South Africa and the Breast Imaging Society of South Africa recommend screening mammography starting at age 40 for women at average risk, together with regular clinical exams (De Lima et al., 2025). Women with a family history or genetic risk may need to start earlier, based on a doctor’s advice.
If You Live With HIV
Always disclose your HIV status to your care team. HIV can affect tumour behaviour and survival (Bauer et al., 2025). Coordinated care between oncology and HIV specialists, along with strict adherence to antiretroviral therapy, greatly improves treatment outcomes. Ongoing monitoring of CD4 counts and viral load during treatment is also important.
Securitas® Financial Group
Making Treatment Financially Workable
Medical Schemes and Prescribed Minimum Benefits (PMBs)
Breast cancer diagnosis and treatment are included in South Africa’s PMBs. This means that if you are on a medical scheme and use designated service providers, PMB-level treatment must be covered in full. Most schemes also offer an oncology “threshold” benefit for additional treatment; once exceeded, co-payments may apply unless PMB rules protect you.
A practical tip is to always register on your scheme’s oncology programme and confirm in writing which treatments are fully covered and where you may face out-of-pocket costs.
Why Gap Cover Is Often Used
Even with PMBs, co-payments and tariff shortfalls can occur. Gap-cover policies, regulated as health insurance, can bridge this gap by covering the difference between what your doctor charges and what your scheme pays. Reviewing your scheme rules alongside any gap cover before starting treatment helps avoid financial shocks.
Final Thoughts
Bringing It Together
The picture in South Africa is shifting. More women are being diagnosed in their 40s, tumours are smaller at presentation, and survival improves when treatment starts quickly. Yet too many are still diagnosed late, especially in under-resourced communities, and HIV continues to complicate outcomes.
Your best defence is early action: knowing your body, attending regular clinical checks, following referrals quickly, and making sure your medical scheme and (if applicable) gap-cover arrangements are in place.
By acting early and planning financially, you can significantly improve your chance of survival and reduce the burden of breast cancer.
If you do not have medical aid or gap cover in place yet, you can reach out to one of our qualified financial advisors to guide you through the process and select the best option for your needs and budget.
If you found this article helpful, consider reading Your Heart Is in Your Hands or Strengthening Your Financial Wellbeing: A Guide for Women. Please consider sharing this article with other women in your life to help spread awareness.